Andrew M. Bellinger

3.8k total citations · 2 hit papers
22 papers, 2.0k citations indexed

About

Andrew M. Bellinger is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Andrew M. Bellinger has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Rheumatology. Recurrent topics in Andrew M. Bellinger's work include CRISPR and Genetic Engineering (5 papers), Ion channel regulation and function (4 papers) and Exercise and Physiological Responses (3 papers). Andrew M. Bellinger is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Ion channel regulation and function (4 papers) and Exercise and Physiological Responses (3 papers). Andrew M. Bellinger collaborates with scholars based in United States, France and Sweden. Andrew M. Bellinger's co-authors include Andrew R. Marks, Marco Mongillo, Alain Lacampagne, Steven Reiken, Stephan E. Lehnart, Lisa Rothman, Steve Reiken, Stéfan Matecki, Xiaoping Liu and Giovanni Traverso and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Andrew M. Bellinger

22 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models

2022 132 citations Richard Lee, Anne Marie Mazzola et al. Circulation profile →
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy

2023 93 citations Lisa N. Kasiewicz, Souvik Biswas et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew M. Bellinger United States	13	1.2k	677	328	247	194	22	2.0k
Satoshi Okumura Japan	31	1.4k 1.2×	793 1.2×	362 1.1×	303 1.2×	125 0.6×	122	2.8k
Giordano Pula United Kingdom	29	1.2k 1.0×	288 0.4×	367 1.1×	337 1.4×	112 0.6×	64	2.4k
Shufang He China	24	940 0.8×	168 0.2×	154 0.5×	234 0.9×	169 0.9×	70	2.1k
Leonid V. Zingman United States	27	2.1k 1.8×	1.4k 2.0×	416 1.3×	253 1.0×	185 1.0×	46	3.7k
Won‐Sik Shim South Korea	21	1.2k 1.1×	190 0.3×	465 1.4×	434 1.8×	119 0.6×	69	2.8k
Ilaria Rivolta Italy	27	2.0k 1.8×	1.6k 2.4×	198 0.6×	623 2.5×	256 1.3×	75	3.1k
Yi Zhao China	36	1.4k 1.2×	326 0.5×	230 0.7×	324 1.3×	598 3.1×	108	3.2k
Jiang Tian United States	18	1.6k 1.4×	249 0.4×	157 0.5×	154 0.6×	250 1.3×	42	2.3k
Eun Hui Lee South Korea	26	1.1k 1.0×	337 0.5×	177 0.5×	418 1.7×	59 0.3×	73	1.8k
Takeshi Yamauchi Japan	23	461 0.4×	471 0.7×	181 0.6×	84 0.3×	171 0.9×	64	1.8k

Countries citing papers authored by Andrew M. Bellinger

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Bellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Bellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Bellinger more than expected).

Fields of papers citing papers by Andrew M. Bellinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Bellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Bellinger. The network helps show where Andrew M. Bellinger may publish in the future.

Co-authorship network of co-authors of Andrew M. Bellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Bellinger. A scholar is included among the top collaborators of Andrew M. Bellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Bellinger. Andrew M. Bellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Richard, Anne Marie Mazzola, Taiji Mizoguchi, et al.. (2024). An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves precise and durable liver editing in nonclinical studies. Atherosclerosis. 395. 118496–118496. 4 indexed citations

Vafai, Scott B., Verena Karsten, Troy Lister, et al.. (2024). Abstract 4139206: Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol. Circulation. 150(Suppl_1). 7 indexed citations

DeNizio, Jamie E., Chaitali Dutta, Victoria Clendaniel, et al.. (2023). An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves potent and LDLR-independent liver editing in mouse models. European Heart Journal. 44(Supplement_2). 8 indexed citations

Kasiewicz, Lisa N., Souvik Biswas, Chaitali Dutta, et al.. (2023). GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy. Nature Communications. 14(1). 2776–2776. 93 indexed citations breakdown →

Macias, Luis A., Sara P. Garcia, Yue Wu, et al.. (2023). Spacer Fidelity Assessments of Guide RNA by Top-Down Mass Spectrometry. ACS Central Science. 9(7). 1437–1452. 8 indexed citations

Bellinger, Andrew M., et al.. (2022). SEQUENTIAL IN VIVO CRISPR BASE EDITING OF THE PCSK9 AND ANGPTL3 GENES IN NON-HUMAN PRIMATES. Journal of the American College of Cardiology. 79(9). 953–953. 1 indexed citations

Khera, Amit V., et al.. (2022). An in vivo CRISPR base editing therapy to inactivate the ANGPTL3 gene: nomination of a development candidate for VERVE-201. European Heart Journal. 43(Supplement_2). 15 indexed citations

Lee, Richard, Anne Marie Mazzola, Maurine Braun, et al.. (2022). Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models. Circulation. 147(3). 242–253. 132 indexed citations breakdown →

Scranton, Richard E., et al.. (2020). Ultra long‐acting oral therapies for Alzheimer's: Proof of principle. Alzheimer s & Dementia. 16(S9). 2 indexed citations

10.

Kanasty, Rosemary, Nupura Bhise, Jung Hyun Yang, et al.. (2019). A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease. Journal of Controlled Release. 303. 34–41. 25 indexed citations

11.

O’Donnell‐Luria, Anne, Alexander Lin, Sai Merugumala, et al.. (2017). Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma. Molecular Genetics and Metabolism. 121(1). 9–15. 8 indexed citations

12.

Zhang, Shiyi, Andrew M. Bellinger, Dean L. Glettig, et al.. (2015). A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices. PMC. 2 indexed citations

13.

Zhang, Shiyi, Andrew M. Bellinger, Dean L. Glettig, et al.. (2015). A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices. Nature Materials. 14(10). 1065–1071. 281 indexed citations

14.

Bellinger, Andrew M., Carlos L. Arteaga, Thomas Force, et al.. (2015). Cardio-Oncology. Circulation. 132(23). 2248–2258. 87 indexed citations

15.

Bellinger, Andrew M., Steve Reiken, Marco Mongillo, et al.. (2009). Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Medicine. 15(3). 325–330. 407 indexed citations

16.

Bellinger, Andrew M., Steven Reiken, Miroslav Důra, et al.. (2008). Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity. Proceedings of the National Academy of Sciences. 105(6). 2198–2202. 262 indexed citations

17.

Bellinger, Andrew M., Marco Mongillo, & Andrew R. Marks. (2008). Stressed out: the skeletal muscle ryanodine receptor as a target of stress. Journal of Clinical Investigation. 118(2). 445–453. 112 indexed citations

18.

Aydin, Jan, Irina G. Shabalina, Nicolas Place, et al.. (2008). Nonshivering thermogenesis protects against defective calcium handling in muscle. The FASEB Journal. 22(11). 3919–3924. 61 indexed citations

19.

Lehnart, Stephan E., Marco Mongillo, Andrew M. Bellinger, et al.. (2008). Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. Journal of Clinical Investigation. 118(6). 2230–45. 307 indexed citations

20.

Yang, Lin, Ao Liu, Sergey I. Zakharov, et al.. (2007). Protein Kinase G Phosphorylates Ca_v1.2 α_1cand β₂Subunits. Circulation Research. 101(5). 465–474. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact